PATENT CLAIM ANALYSIS

Application Number: 16125941
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["424", "428000"]

Abstract:
Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions,

Claim (Index 9):
The method of  claim 4 , wherein the implant degrades at a rate effective to\n sustain release of an amount of the TKI from the implant effective to treat the ocular condition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.57407
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13970001', '11119463', '11119001', '14992592', '13527344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8383044210797087
- 35 USC 102 Novelty (BERT): 0.5988531416312076
- Combined Prediction Score: 0.8143592931348587
- Mean Citation Score: 644.3696719999998
- Max Citation Score: 663.7472
- Similarity Product: 416.6336631368637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test